Pfizer (PFE)
AI-powered earnings call analysis for Pfizer. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.
Subscribe
Subscribe
Get Episode Notifications
Get an email when new Pfizer earnings episodes are released.
Next Episode
Pfizer earnings call scheduled for Feb 2, 2027 (before market open)
New episode expected Feb 3, 2027
Latest Episode
Q3 2026 Earnings
7:16 • 11/3/2026
All Episodes
Q3 2026 Earnings
7:16Pfizer raised FY26 guidance ($62-64B revenue, $2.95-3.05 EPS) on strong non-COVID (+7%) and acquired growth (+32%), supported by advancing pipeline targeting high single-digit CAGR through 2033.
Q2 2026 Earnings
6:50Pfizer delivered Q2 2026 revenue of $15B (+1% YoY, +5% ex-COVID) with adjusted EPS of $0.77, raising full-year guidance by $500M while expanding cost savings to $9.7B through 2029.
Q1 2026 Earnings
8:25Pfizer delivered strong Q1 2026 results with $14.5B revenue and $0.75 adjusted EPS, driven by 22% growth in launched/acquired products and robust non-COVID performance, while reaffirming full-year guidance and highlighting pipeline progress in oncology and obesity.
Q4 2025 Earnings
8:32AI-generated analysis of PFE's Q4 2025 earnings call.
